WO2002030483A1 - Moisture curable balloon materials - Google Patents

Moisture curable balloon materials Download PDF

Info

Publication number
WO2002030483A1
WO2002030483A1 PCT/US2001/018515 US0118515W WO0230483A1 WO 2002030483 A1 WO2002030483 A1 WO 2002030483A1 US 0118515 W US0118515 W US 0118515W WO 0230483 A1 WO0230483 A1 WO 0230483A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
balloon
hydrolyzable
polymeric material
hydrolyzable silane
Prior art date
Application number
PCT/US2001/018515
Other languages
French (fr)
Inventor
John Jianhua Chen
Original Assignee
Scimed Life Systems, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scimed Life Systems, Inc. filed Critical Scimed Life Systems, Inc.
Priority to JP2002533922A priority Critical patent/JP2004518460A/en
Priority to AT01944353T priority patent/ATE301479T1/en
Priority to AU2001266775A priority patent/AU2001266775A1/en
Priority to DE60112598T priority patent/DE60112598T2/en
Priority to EP01944353A priority patent/EP1324784B1/en
Priority to CA002425261A priority patent/CA2425261A1/en
Publication of WO2002030483A1 publication Critical patent/WO2002030483A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/04Macromolecular materials
    • A61L29/06Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1027Making of balloon catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/104Balloon catheters used for angioplasty
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1088Balloon catheters with special features or adapted for special applications having special surface characteristics depending on material properties or added substances, e.g. for reducing friction
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/13Hollow or container type article [e.g., tube, vase, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/13Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1334Nonself-supporting tubular film or bag [e.g., pouch, envelope, packet, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/13Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1334Nonself-supporting tubular film or bag [e.g., pouch, envelope, packet, etc.]
    • Y10T428/1345Single layer [continuous layer]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/13Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1352Polymer or resin containing [i.e., natural or synthetic]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/13Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1352Polymer or resin containing [i.e., natural or synthetic]
    • Y10T428/1386Natural or synthetic rubber or rubber-like compound containing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/13Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1352Polymer or resin containing [i.e., natural or synthetic]
    • Y10T428/1397Single layer [continuous layer]

Definitions

  • the present invention relates to the preparation of thin films useful in medical devices, and in particular in the manufacture of medical dilatation balloons, formed from a durable polymeric composition crosslinked upon exposure to moisture through --Si— O— Si— linkages. More particularly, the balloons are formed from the reaction product of at least one organofunctional hydrolyzable silane and at least one polymer, the reaction product of which is crosslinked by exposure to moisture.
  • the crosslinked structure increases the toughness, abrasion resistance, durability and dimension stability of the material during both manufacturing procedures and during use.
  • Balloon catheters are used in procedures relating to the treatment of stenoses or blockages in body vessels, an example of which is an arterial stenosis which is commonly treated by angioplasty procedures which involve the insertion of balloon catheters into the affected blood vessel of the patient.
  • the balloon may function to widen a vessel into which the catheter is inserted, to force open a blocked vessel to open the blocked or collapsed blood vessel, or to prop open the a collapsed vessel.
  • the requirements for strength and size of the balloons vary widely depending on the balloon's intended use and the vessel size into which the catheter is inserted. Perhaps the most demanding applications for such balloons are in balloon angioplasty in which catheters are inserted for long distances into extremely small vessels and used to open stenoses of blood vessels by balloon inflation. Balloon angioplasty requires extremely thin walled, high strength (i.e. high tensile), relatively inelastic balloons of predictable inflation properties.
  • Thin walls are necessary because the balloon's wall and waist thicknesses limit the minimum diameter of the distal end of the catheter and therefore determine the limits on vessel size treatable by the method and the ease of passage of the catheter through the vascular system.
  • High strength is necessary because the balloon is used to push open a stenosis and so the thin wall must not burst under the high internal pressures necessary to accomplish this task.
  • the balloon must have some elasticity so that the inflated diameter can be controlled, so as to allow the surgeon to vary the balloon's diameter as required to treat individual lesions, but that elasticity must be relatively low so that the diameter is easily controllable. Small variations in pressure must not cause wide variation in diameter.
  • catheter balloons are often made of biaxially oriented polyethylene terephthalate (PET) or a polyamide material such as nylon 12. These materials, however, tend to be less elastic, and have less resilience. Balloon catheters may also be made of more elastic materials such as polyolefins or polyolefin copolymers, but typically, in order to achieve the high tensile strength, the balloon walls must be made thicker.
  • PET polyethylene terephthalate
  • nylon 12 polyamide material
  • Balloon catheters may also be made of more elastic materials such as polyolefins or polyolefin copolymers, but typically, in order to achieve the high tensile strength, the balloon walls must be made thicker.
  • the balloons can be coated with a more abrasion resistant material, but coatings add a step during the manufacturing process, typically decrease flexibility, and also typically increase the wall thickness.
  • a balloon catheter which is thin walled, durable, abrasion and tear resistant thereby improving the resistance to pinhole formation, and is relatively flexible, yet inelastic to allow the balloons to expand outwardly to a predetermined diameter, and then cease further expansion at normal pressures, to avoid damage to the artery wall by overexpansion.
  • the present invention relates to a medical device such as a balloon catheter comprising a dilatation balloon wherein said balloon comprises a moisture cured polymeric material which is crosslinked through — Si-O-Si— linkages.
  • a catheter balloon comprising the reaction product of at least one polymer and at least one organofunctional hydrolyzable silane having an organofunctional group capable of readily reacting with the moieties on the polymer backbone.
  • the silane is grafted onto the polymer backbone and the hydrolyzable groups of the silane are activated by moisture, crosslinking the structure through --Si-O-Si-- linkages.
  • the present invention further relates to a medical device comprising a dilatation balloon formed from a crosslinked polymeric material, the crosslinked polymeric material comprises the reaction product of at least one polymer and at least one hydrolyzable silane having the following general structure:
  • X is a monovalent non-hydrolyzable organic moiety comprising at least one functional group W which is reactive with said polymer with the proviso that an Si-C bond is present between Si and W
  • Y is a hydrolyzable group
  • Z is a monovalent hydrocarbon group
  • m is an integer from 1 to 3.
  • the hydrolyzable silane groups, Y of the silane are then activated with moisture to form a durable, tough, high strength, excellent abrasion resistant polymeric material crosslinked through — Si— O— Si— linkages.
  • the balloon structure also has dimension stability during both manufacturing procedures and in use.
  • the high strength crosslinked material allows the balloons to be manufactured having of a relatively thin walled structure.
  • the present invention further relates to a method of forming a catheter balloon comprising the steps of providing at least one polymeric material at or above its melt temperature, providing at least one organofunctional hydrolyzable silane compound, extruding the polymeric material and the organofunctional hydrolyzable silane compound into a tubular preform at a temperature wherein the polymeric material and the hydrolyzable silane react, forming the tubular preform into a balloon preform, blowing the balloon preform into a balloon, and exposing the balloon or balloon preform to water.
  • the hydrolyzable groups on the silane are activated by moisture forming a durable polymeric material crosslinked through --Si-O-Si— linkages..
  • Fig. 1 is a perspective view of a dilatation catheter having attached at its distal end, a catheter balloon of the present invention depicted in its inflated state.
  • the present invention relates to medical balloons that are made of a durable polymeric material crosslinked through —Si-O-Si— linkages.
  • the method of preparing the medical balloons of the present invention involves the grafting of hydrolyzable silanes onto a polymer backbone and then moisture curing the resultant polymeric structure.
  • the hydrolyzable groups of the silane are activated upon exposure to moisture forming durable — Si— O— Si— linkages.
  • the general reaction scheme representative of the grafting/moisture curing reaction of the present invention generally involves a two-step reaction process in which the first step is the reaction between the hydrolyzable silane compound and the polymer at melt in the absence of moisture, and the second step is the crosslinking reaction in which the hydrolyzable groups of the silane are activated with moisture forming the durable — Si ⁇ O ⁇ Si- linkages.
  • This two step process can be represented by the following general reaction scheme.
  • the first step of the diagram illustrates the reaction between the polymer and the hydrolyzable silane compound.
  • the second and third reactions illustrate hydrolysis and condensation of the polymer to form the —Si— O— Si— linkages.
  • the latter two reactions occur basically simultaneously and are considered to be the second step. ⁇ 3H 2 0
  • the silanes useful herein include those having hydrolyzable groups, each of which is bonded to the silicon atom and that will effectively graft and crosslink to a polymer backbone.
  • Hydrolyzable groups include Cj to C 12 alkoxy groups, in particular the lower to C 4 alkoxy groups such as methoxy or ethoxy, C 2 to C 4 acryloxy, up to about C 6 (poly)alkoxyalkoxy, phenoxy, oxime, amine, halogen groups including chlorine, fluorine and bromine, and so forth.
  • hydrolyzable groups including the alkoxy, alkoxyalkoxy and the acryloxy groups are used.
  • the hydrolyzable groups, the alkoxy groups for instance, will be activated by moisture to form durable structures crosslinked through — Si-O— Si— linkages.
  • organofunctional hydrolyzable silanes useful herein may be broadly represented by the following general structure:
  • X is a monovalent non-hydrolyzable organic moiety comprising at least one functional group W which is reactive with the polymeric material to which the silane is to be grafted with the proviso that at least one Si-C bond is present between Si and W
  • Y is a hydrolyzable group
  • Z is a monovalent hydrocarbon group
  • m is an integer from 1 to 3.
  • the hydrolyzable silane is useful from about 0.05 wt-% to about 20 wt-% of the polymer/silane composition.
  • W may be, but is not limited to, (meth)acrylamido, (meth)acryloxy, carboxyl, epoxy, amino, ureido, isocyanato, thiocyanato, mercapto, haloalkyl, styryl, vinyl, allyl, sulfonyl azide, acid anhydride, or carboxylic acid esters of aromatic alcohols, the alcohols of which have 2 to 15 carbon atoms, and mixtures thereof.
  • X is epoxycylohexyl, glycidoxypropyl, isocyanatopropyl, vinyl or allyl.
  • Other examples of X include, but are not limited to, 3-acryloxypropyl, 3-methacryloxypropyl, 3 -glycidoxypropyl,
  • Y is C ⁇ to C 4 alkoxy
  • m is 2 or 3.
  • Some examples of specific unsaturated silanes represented by formula II) above that are useful herein include, but are not limited to, those that comprise an ethylenically unsaturated hydrocarbyl group, such as a vinyl, allyl, isopropenyl, butenyl, cyclohexenyl or ⁇ -(meth)acryloxyalkyl group, and a hydrolyzable group, such as, for example, a hydrocarbyloxy, hydrocarbonyloxy, or hydrocarbylamino group.
  • hydrolyzable groups include methoxy, ethoxy, formyloxy, acetoxy, proprionyloxy, and alkyl or arylamino groups.
  • Preferred silanes of this category are the unsaturated alkoxy silanes which can be grafted onto the polymer.
  • hydrolyzable silanes useful herein include those represented by the following general formula:
  • R' is a hydrogen atom or lower Cj to C 4 alkyl, particularly methyl; x and y are 0 or 1 with the proviso that when x is 1, y is 1 ; n is an integer from 1 to 12 inclusive, preferably 1 to 4, and each R independently is a hydrolyzable organic group such as an alkoxy group having from 1 to 12 carbon atoms (e.g. methoxy, ethoxy, butoxy), aryloxy group (e.g. phenoxy), araloxy group (e.g. benzyloxy), aliphatic acyloxy group having from 1 to 12 carbon atoms (e.g.
  • silanes useful herein include but are not limited to, 3 -acryloxypropyltrimethoxysilane, 3 -methacryloxypropyltimethoxy silane, 3-methacryloxypropyltris(methoxyethoxy)silane, 3-glycidoxypropyltrimethoxysilane, (3-glycidoxypropyl)methyldiethoxysilane, 3-aminopropyltriethoxysilane, 2-(3 ,4-epoxycyclohexyl)ethyltrimethoxy silane, (3 -aminopropyl)methyldiethoxysilane, N-(2-aminoethyl)-3-aminopropyltrimethoxysilane, N-(2-aminoethyl)-3-aminopropylmethyldimethoxysilane, (aminoethylaminomethyl)phenethyltrimethoxysilane, 3 -( 1 -amino
  • Suitable polymers include, but are not limited to, polyolefms such as polyethylene and polypropylene, and substantially linear ethylene and propylene ⁇ - olefins; acrylic polymers; copolymers of olef ⁇ ns and acrylic acid ester copolymers thermoplastic or elastomeric polyurethanes; thermoplastic or elastomeric polyesters; polyamides; polysulfones; polyvinyls; and so forth.
  • polyolefms such as polyethylene and polypropylene, and substantially linear ethylene and propylene ⁇ - olefins
  • acrylic polymers copolymers of olef ⁇ ns and acrylic acid ester copolymers thermoplastic or elastomeric polyurethanes
  • thermoplastic or elastomeric polyesters thermoplastic or elastomeric polyesters
  • polyamides polysulfones
  • polyvinyls polyvinyls
  • an amino functional polymer is reacted with an isocyanate functional hydrolyzable silane.
  • Poly(meth)acrylate polymers having pendant hydroxy groups thereon can be also be reacted with isocyanato functional alkoxysilanes.
  • These types of reactions have been found to have particular utility herein.
  • an example of a reaction between the isocyanate functional silane compound, isocyanatopropyltriethoxy silane, and an amine containing polymer may be represented by the following general reaction scheme:
  • a specific method of grafting an unsaturated hydrolyzable silane onto the backbone of a polymer is by a free radical mechanism in which a free radical initiator, such as an organic peroxide, is used.
  • the following reaction mechanism is representative of an unsaturated silane, i.e. in this case a vinyl containing silane, reacted onto a polmer backbone by a free radical mechanism using a peroxide as the free radical initiator.
  • the second part of the reaction process is a moisture curing step in which the hydrolyzable alkoxy groups of the silane in the presence of moisture, react to form polymers which are crosslinked by the presence of —Si— O— Si— linkages.
  • These crosslinked polymers provide structures which are more durable, abrasion resistant, tear resistant and dimensionally stable during sterilization than non-crosslinked polymeric materials.
  • the resultant crosslinked material finds particular utility in medical devices, especially in angioplasty catheter balloons where the durability and toughness are especially important.
  • a tubular preform is first prepared by mild blending and extruding the amine containing polymeric material and the functional silane compound together at a temperature of greater than the metling temperature of the polymer(s) in the absence of moisture.
  • the tubular preform may be prepared using any extrusion techniques known in the art.
  • the tubular preform may then be fed into a balloon mold.
  • the balloon is then exposed to moisture in some form in order to produce the crosslinked balloon structure of the present invention.
  • This exposure to moisture may occur by actually forming the balloon in a water bath at temperatures and pressures typically used for balloon formation, or it may occur after balloon formation, for instance by placing the already formed balloon in a water bath with or without pressure.
  • Balloons are typically formed using a blow molding technique.
  • balloon formation may be carried out in any conventional manner with conventional extrusion and blowing techniques, but basically there are three major steps in the process which include extruding the tubular preform, blow molding the balloon and annealing the balloon.
  • the preform may be axially stretched and/or biaxially oriented before it is blown. General techniques for balloon formation are discussed in U.S. Patent No.
  • Fig. 1 is a perspective view of dilatation catheter shown in its inflated state having attached at its distal end a catheter balloon shown generally at 10.
  • Catheter balloon 14 is formed of the crosslinked polymeric material of the present invention and is conventional in its structure having a body portion 12, cone portions 14 and waist portion 16.
  • the moisture cured polymeric materials of the present invention may be utilized in any catheter balloon configuration capable of being formed from a polymeric material, and that numerous modifications can be made to these structures without departing from the spirit and scope of the present invention.
  • the exposure of the alkoxy groups of the silane to moisture results in the crosslinking reaction.
  • the balloon may be kept in the hot water bath under pressure and tension at conventional molding temperatures such as in the range of about
  • the resultant process for manufacturing the improved balloons of the present invention is thus very simple without the introduction of extra steps into the process of preparing the tubular preform.

Abstract

The present invention relates to a catheter device having a dilatation balloon formed from a polymeric material crosslinked by moisture through --Si--O--Si-- linkages, and to a method of making the same. The polymeric material is formed by reacting at least one organofunctional hydrolyzable silane with at least one polymer. The crosslinked polymeric structure is ideal for forming more resilient and durable catheter balloons. In particular, the catheter balloons have excellent abrasion resistance.

Description

MOISTURE CURABLE BALLOON MATERIALS
FIELD OF THE INVENTION
The present invention relates to the preparation of thin films useful in medical devices, and in particular in the manufacture of medical dilatation balloons, formed from a durable polymeric composition crosslinked upon exposure to moisture through --Si— O— Si— linkages. More particularly, the balloons are formed from the reaction product of at least one organofunctional hydrolyzable silane and at least one polymer, the reaction product of which is crosslinked by exposure to moisture. The crosslinked structure increases the toughness, abrasion resistance, durability and dimension stability of the material during both manufacturing procedures and during use.
BACKGROUND OF THE INVENTION
Balloon catheters are used in procedures relating to the treatment of stenoses or blockages in body vessels, an example of which is an arterial stenosis which is commonly treated by angioplasty procedures which involve the insertion of balloon catheters into the affected blood vessel of the patient.
The balloon may function to widen a vessel into which the catheter is inserted, to force open a blocked vessel to open the blocked or collapsed blood vessel, or to prop open the a collapsed vessel. The requirements for strength and size of the balloons vary widely depending on the balloon's intended use and the vessel size into which the catheter is inserted. Perhaps the most demanding applications for such balloons are in balloon angioplasty in which catheters are inserted for long distances into extremely small vessels and used to open stenoses of blood vessels by balloon inflation. Balloon angioplasty requires extremely thin walled, high strength (i.e. high tensile), relatively inelastic balloons of predictable inflation properties.
Thin walls are necessary because the balloon's wall and waist thicknesses limit the minimum diameter of the distal end of the catheter and therefore determine the limits on vessel size treatable by the method and the ease of passage of the catheter through the vascular system. High strength is necessary because the balloon is used to push open a stenosis and so the thin wall must not burst under the high internal pressures necessary to accomplish this task. The balloon must have some elasticity so that the inflated diameter can be controlled, so as to allow the surgeon to vary the balloon's diameter as required to treat individual lesions, but that elasticity must be relatively low so that the diameter is easily controllable. Small variations in pressure must not cause wide variation in diameter.
To achieve the high strength, thin walled properties, catheter balloons are often made of biaxially oriented polyethylene terephthalate (PET) or a polyamide material such as nylon 12. These materials, however, tend to be less elastic, and have less resilience. Balloon catheters may also be made of more elastic materials such as polyolefins or polyolefin copolymers, but typically, in order to achieve the high tensile strength, the balloon walls must be made thicker.
One difficulty experienced in the case of the high strength, thin walled materials, such as PET is that they can be punctured through abrasion or the like, even though they have a high tensile strength. Pin holes and ruptures can occur when such catheter balloons are used in contact with rough surfaces. Also, tiny flaws in the mold of such balloons can create weak spots, since the balloons are so thin-walled.
It is, however, typically impractical to increase the wall thickness of these biaxially oriented, non-resilient materials because they become too stiff, with high flexural moduli, with the result that such balloons do not collapse properly on deflation to facilitate easy withdrawal from the vascular system of a patient.
The balloons can be coated with a more abrasion resistant material, but coatings add a step during the manufacturing process, typically decrease flexibility, and also typically increase the wall thickness. There remains a need for a balloon catheter which is thin walled, durable, abrasion and tear resistant thereby improving the resistance to pinhole formation, and is relatively flexible, yet inelastic to allow the balloons to expand outwardly to a predetermined diameter, and then cease further expansion at normal pressures, to avoid damage to the artery wall by overexpansion. SUMMARY OF THE INVENTION
The present invention relates to a medical device such as a balloon catheter comprising a dilatation balloon wherein said balloon comprises a moisture cured polymeric material which is crosslinked through — Si-O-Si— linkages. The present invention further relates to a catheter balloon comprising the reaction product of at least one polymer and at least one organofunctional hydrolyzable silane having an organofunctional group capable of readily reacting with the moieties on the polymer backbone. The silane is grafted onto the polymer backbone and the hydrolyzable groups of the silane are activated by moisture, crosslinking the structure through --Si-O-Si-- linkages.
The present invention further relates to a medical device comprising a dilatation balloon formed from a crosslinked polymeric material, the crosslinked polymeric material comprises the reaction product of at least one polymer and at least one hydrolyzable silane having the following general structure:
X — Si-Ym
Z (3- )
where X is a monovalent non-hydrolyzable organic moiety comprising at least one functional group W which is reactive with said polymer with the proviso that an Si-C bond is present between Si and W, Y is a hydrolyzable group, Z is a monovalent hydrocarbon group, and m is an integer from 1 to 3. The hydrolyzable silane groups, Y of the silane are then activated with moisture to form a durable, tough, high strength, excellent abrasion resistant polymeric material crosslinked through — Si— O— Si— linkages. The balloon structure also has dimension stability during both manufacturing procedures and in use. The high strength crosslinked material allows the balloons to be manufactured having of a relatively thin walled structure.
The present invention further relates to a method of forming a catheter balloon comprising the steps of providing at least one polymeric material at or above its melt temperature, providing at least one organofunctional hydrolyzable silane compound, extruding the polymeric material and the organofunctional hydrolyzable silane compound into a tubular preform at a temperature wherein the polymeric material and the hydrolyzable silane react, forming the tubular preform into a balloon preform, blowing the balloon preform into a balloon, and exposing the balloon or balloon preform to water. The hydrolyzable groups on the silane are activated by moisture forming a durable polymeric material crosslinked through --Si-O-Si— linkages..
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a perspective view of a dilatation catheter having attached at its distal end, a catheter balloon of the present invention depicted in its inflated state.
DETAILED DESCRIPTIONS OF THE PREFERRED EMBODIMENTS
The present invention relates to medical balloons that are made of a durable polymeric material crosslinked through —Si-O-Si— linkages.
The method of preparing the medical balloons of the present invention involves the grafting of hydrolyzable silanes onto a polymer backbone and then moisture curing the resultant polymeric structure. The hydrolyzable groups of the silane are activated upon exposure to moisture forming durable — Si— O— Si— linkages.
The general reaction scheme representative of the grafting/moisture curing reaction of the present invention generally involves a two-step reaction process in which the first step is the reaction between the hydrolyzable silane compound and the polymer at melt in the absence of moisture, and the second step is the crosslinking reaction in which the hydrolyzable groups of the silane are activated with moisture forming the durable — Si~O~ Si- linkages.
This two step process can be represented by the following general reaction scheme. The first step of the diagram illustrates the reaction between the polymer and the hydrolyzable silane compound. The second and third reactions illustrate hydrolysis and condensation of the polymer to form the —Si— O— Si— linkages. The latter two reactions occur basically simultaneously and are considered to be the second step. Δ 3H20
I) -R + Y(CH2)πSi(OCH3)3 → R-Y(CH2)nSi(OCH3)3 →→→ R-Y(CH2)nSi(OH)3
-3CH3OH
→→ -R-Y(CH2)nSi(OH)2-O-Si(OH)2(CH2)nY-R-
-H20
The silanes useful herein include those having hydrolyzable groups, each of which is bonded to the silicon atom and that will effectively graft and crosslink to a polymer backbone. Hydrolyzable groups include Cj to C12 alkoxy groups, in particular the lower to C4 alkoxy groups such as methoxy or ethoxy, C2 to C4 acryloxy, up to about C6 (poly)alkoxyalkoxy, phenoxy, oxime, amine, halogen groups including chlorine, fluorine and bromine, and so forth. In particular emodiments of the present invention, hydrolyzable groups including the alkoxy, alkoxyalkoxy and the acryloxy groups are used. The hydrolyzable groups, the alkoxy groups for instance, will be activated by moisture to form durable structures crosslinked through — Si-O— Si— linkages.
The organofunctional hydrolyzable silanes useful herein may be broadly represented by the following general structure:
ID *-Si-Ym
Z(3-m)
where X is a monovalent non-hydrolyzable organic moiety comprising at least one functional group W which is reactive with the polymeric material to which the silane is to be grafted with the proviso that at least one Si-C bond is present between Si and W, Y is a hydrolyzable group, Z is a monovalent hydrocarbon group, and m is an integer from 1 to 3. The hydrolyzable silane is useful from about 0.05 wt-% to about 20 wt-% of the polymer/silane composition.
W may be, but is not limited to, (meth)acrylamido, (meth)acryloxy, carboxyl, epoxy, amino, ureido, isocyanato, thiocyanato, mercapto, haloalkyl, styryl, vinyl, allyl, sulfonyl azide, acid anhydride, or carboxylic acid esters of aromatic alcohols, the alcohols of which have 2 to 15 carbon atoms, and mixtures thereof.
In particular embodiments X is epoxycylohexyl, glycidoxypropyl, isocyanatopropyl, vinyl or allyl. Other examples of X include, but are not limited to, 3-acryloxypropyl, 3-methacryloxypropyl, 3 -glycidoxypropyl,
2-(3 ,4-epoxy cyclohexyl)ethyl, 3 -aminopropyl, N-(2-aminoethyl)-3 -aminopropyl, (aminoethylaminomethyl)phenethyl, 3 -( 1 -aminopropoxy)-3 ,3 -dimethyl- 1 -propenyl, N-phenylaminopropyl, diethylenetriaminopropyl, and 3-ureidopropyl. Organofunctional moieties containing amino functional groups or isocyanato functional groups are particularly versatile in having reactivity or compatibility with a wide range of different polymer types.
In particular embodiments, Y is Cλ to C4 alkoxy, and m is 2 or 3.
Some examples of specific unsaturated silanes represented by formula II) above that are useful herein include, but are not limited to, those that comprise an ethylenically unsaturated hydrocarbyl group, such as a vinyl, allyl, isopropenyl, butenyl, cyclohexenyl or γ-(meth)acryloxyalkyl group, and a hydrolyzable group, such as, for example, a hydrocarbyloxy, hydrocarbonyloxy, or hydrocarbylamino group. Examples of hydrolyzable groups include methoxy, ethoxy, formyloxy, acetoxy, proprionyloxy, and alkyl or arylamino groups. Preferred silanes of this category are the unsaturated alkoxy silanes which can be grafted onto the polymer.
Some of these unsaturated silanes and their method of preparation are more fully described in US 5312861 and US 5266627, both of which are incorporated by reference herein in their entirety. Specific examples of these silanes for use herein are vinyl trimethoxy silane, vinyl triethoxy silane, γ-(meth)acryloxy propyl trimethoxy silane, allyltrimethoxysilane, and so forth.
A particular class of hydrolyzable silanes useful herein include those represented by the following general formula:
Figure imgf000007_0001
where R' is a hydrogen atom or lower Cj to C4 alkyl, particularly methyl; x and y are 0 or 1 with the proviso that when x is 1, y is 1 ; n is an integer from 1 to 12 inclusive, preferably 1 to 4, and each R independently is a hydrolyzable organic group such as an alkoxy group having from 1 to 12 carbon atoms (e.g. methoxy, ethoxy, butoxy), aryloxy group (e.g. phenoxy), araloxy group (e.g. benzyloxy), aliphatic acyloxy group having from 1 to 12 carbon atoms (e.g. formyloxy, acetyloxy, propanoyloxy), amino or substituted amino groups (alkylamino, arylamino), or a lower alkyl group having 1 to 6 carbon atoms inclusive, with the proviso that not more than one of the three R groups is an alkyl.
Other silanes useful herein include but are not limited to, 3 -acryloxypropyltrimethoxysilane, 3 -methacryloxypropyltimethoxy silane, 3-methacryloxypropyltris(methoxyethoxy)silane, 3-glycidoxypropyltrimethoxysilane, (3-glycidoxypropyl)methyldiethoxysilane, 3-aminopropyltriethoxysilane, 2-(3 ,4-epoxycyclohexyl)ethyltrimethoxy silane, (3 -aminopropyl)methyldiethoxysilane, N-(2-aminoethyl)-3-aminopropyltrimethoxysilane, N-(2-aminoethyl)-3-aminopropylmethyldimethoxysilane, (aminoethylaminomethyl)phenethyltrimethoxysilane, 3 -( 1 -aminopropoxy)-3 ,3 -dimethyl- 1 -propenyltrimethoxysilane, N-phenylaminopropyltrimethoxy silane, (3 -trimethoxy silylpropyl)diethylenetriamine, ureidopropyltriethoxysilane, 3 -isocyanatopropyltriethoxysilane, 3 -thiocy anatopropy ltriethoxy silane, 3 -mercaptopropyltriethoxysilane, 3-(N-styrylmethyl-2-aminoethylamino)propyltrimethoxysilane hydrochloride, phenyltriethoxysilane, phenethyltrimethoxysilane, (p-chloromethyl)phenyltrimethoxysilane, (chloromethyl)phenylethyltrimethoxysilane, and so forth.
Suitable polymers include, but are not limited to, polyolefms such as polyethylene and polypropylene, and substantially linear ethylene and propylene α- olefins; acrylic polymers; copolymers of olefϊns and acrylic acid ester copolymers thermoplastic or elastomeric polyurethanes; thermoplastic or elastomeric polyesters; polyamides; polysulfones; polyvinyls; and so forth. The incorporation of silanes into polyamides, as well as other polymers including polyolefins, is discussed in US 4637640 and in US 5055249 both of which are incorporated by reference herein in their entirety.
Some specific embodiments of the present invention are represented by the following reaction mechanisms. In some specific embodiments, an amino functional polymer, is reacted with an isocyanate functional hydrolyzable silane. Poly(meth)acrylate polymers having pendant hydroxy groups thereon can be also be reacted with isocyanato functional alkoxysilanes. These types of reactions have been found to have particular utility herein. For instance, an example of a reaction between the isocyanate functional silane compound, isocyanatopropyltriethoxy silane, and an amine containing polymer may be represented by the following general reaction scheme:
IV) OCH3 — NH2 + O=C=N — CH2CH2CH2— Si— OCH3
OCH 3
— NH — CH3
Figure imgf000009_0001
An example of a reaction in which a silane compound having epoxy functionality is reacted with a polymer having amine functionality may be represented by the following general reaction scheme:
N) — NH2 + C κH°2_\C H2_C H _0_C 3He_ ?SjC-_H°oCH3 *
OCH3
?H O H3 I I NH CH2-CH— CH2 — O — C3H6— Si — OCH3
OCH3 Another example of a reaction between a different epoxy functional silane and a polymeric amine containing compound may be represented by the following general reaction scheme:
Figure imgf000010_0001
A specific method of grafting an unsaturated hydrolyzable silane onto the backbone of a polymer is by a free radical mechanism in which a free radical initiator, such as an organic peroxide, is used.
The following reaction mechanism is representative of an unsaturated silane, i.e. in this case a vinyl containing silane, reacted onto a polmer backbone by a free radical mechanism using a peroxide as the free radical initiator.
peroxide
VII) — Si — CH =CH. + polymer ». -Si—CH2CH2 heat, h
The second part of the reaction process is a moisture curing step in which the hydrolyzable alkoxy groups of the silane in the presence of moisture, react to form polymers which are crosslinked by the presence of —Si— O— Si— linkages. These crosslinked polymers provide structures which are more durable, abrasion resistant, tear resistant and dimensionally stable during sterilization than non-crosslinked polymeric materials. The resultant crosslinked material finds particular utility in medical devices, especially in angioplasty catheter balloons where the durability and toughness are especially important.
In the preparation of the medical devices of the present invention, a tubular preform is first prepared by mild blending and extruding the amine containing polymeric material and the functional silane compound together at a temperature of greater than the metling temperature of the polymer(s) in the absence of moisture. The tubular preform may be prepared using any extrusion techniques known in the art.
The tubular preform may then be fed into a balloon mold. The balloon is then exposed to moisture in some form in order to produce the crosslinked balloon structure of the present invention. This exposure to moisture may occur by actually forming the balloon in a water bath at temperatures and pressures typically used for balloon formation, or it may occur after balloon formation, for instance by placing the already formed balloon in a water bath with or without pressure. Balloons are typically formed using a blow molding technique. However, balloon formation may be carried out in any conventional manner with conventional extrusion and blowing techniques, but basically there are three major steps in the process which include extruding the tubular preform, blow molding the balloon and annealing the balloon. The preform may be axially stretched and/or biaxially oriented before it is blown. General techniques for balloon formation are discussed in U.S. Patent No.
4,490,421 to Levy and in U.S. Patent no. 5,348,538 issued September 20, 1994 to Wang et al. Fig. 1 is a perspective view of dilatation catheter shown in its inflated state having attached at its distal end a catheter balloon shown generally at 10. Catheter balloon 14 is formed of the crosslinked polymeric material of the present invention and is conventional in its structure having a body portion 12, cone portions 14 and waist portion 16. One of skill in the art will recognize that the moisture cured polymeric materials of the present invention may be utilized in any catheter balloon configuration capable of being formed from a polymeric material, and that numerous modifications can be made to these structures without departing from the spirit and scope of the present invention. The exposure of the alkoxy groups of the silane to moisture results in the crosslinking reaction. After forming, the balloon may be kept in the hot water bath under pressure and tension at conventional molding temperatures such as in the range of about
65° C to about 145° C for a predetermined time to ensure completion of the crosslinking process. Any remaining uncrosslinked functional groups, however, will undergo crosslinking over time. The resultant process for manufacturing the improved balloons of the present invention is thus very simple without the introduction of extra steps into the process of preparing the tubular preform.
As compared to some prior art methods, there is no requirement for radiation or e-beams using the method of the present invention. One disadvantage known to using e-beams is that it is difficult to get a full cure without any chain scission occuring. Further, the e-beam process is not economical.
The embodiments described herein are in no way intended to limit the present invention and one of skill in the art will recognize that modifications can be made without departing from the spirit and scope of the present invention.

Claims

CLAIMS:
1. A medical device formed of moisture curable materials, comprising: a dilatation balloon formed from a crosslinked polymeric material, the crosslinked polymeric material comprising the reaction product of: I) at least one polymer; and
II) at least one hydrolyzable silane having the following general structure:
X — Si— Y, m
(3-m)
where X is a monovalent non-hydrolyzable organic moiety comprising at least one functional group W which is reactive with said polymer with the proviso that an Si-C bond is present between Si and W, Y is a hydrolyzable group, Z is a monovalent hydrocarbon group, and m is an integer from 1 to 3 ; said reaction product having been further reacted with moisture to produce a polymeric material crosslinked through —Si— O— Si— linkages.
2. The device of Claim 1 wherein Y is an alkoxy group having from 1 to 4 carbon atoms.
3. The device of Claim 1 wherein W is selected from (meth)acrylamido, (meth)acryloxy, carboxyl, epoxy, amino, ureido, isocyanato, thiocyanato, mercapto, styryl, vinyl, allyl, haloalkyl, acid anhydride, sulfonyl azide, carboxylic acid esters of aromatic alcohols, and mixtures thereof.
4. The device of Claim 1 wherein X is selected from epoxycyclohexyl, glycidoxypropyl, isocyanatopropyl, vinyl, and allyl.
5. The device of Claim 1 wherein said at least one hydrolyzable silane comprises an organofunctional group capable of readily reacting with a primary or secondary amine and said at least one polymer is an amino functional polymer.
6. The catheter device of Claim 1 wherein said hydrolyzable silane is selected from isocyanatoalkylalkoxysilanes, glycidoxyalkylalkoxysilanes and epoxycylcohexylalkylalkoxysilanes.
5
7. The device of Claim 6 wherein said hydrolyzable silane is selected form isocyanatopropyltriethoxysilane, glycidoxypropyltrimethoxysilane and 2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane.
10 8. The device of Claim 1 wherein at least one hydrolyzable silane has the following general structure:
R'
CH2 =C -^-C — O CnH2n) y)χSiRa
15
where R' is a hydrogen atom or lower Cj to C4 alkyl; x and y are 0 or 1 with the proviso that when x is 1, y is 1; n is an integer from 1 to 12 inclusive, preferably 1 to 4, and each R independently is a hydrolyzable organic group such as an 20 alkoxy group having from 1 to 12 carbon atoms, aryloxy group, aralkoxy group, aliphatic acyloxy group having from 1 to 12 carbon atoms, amino or substituted amino groups, or a lower alkyl group having 1 to 6 carbon atoms inclusive, with the proviso that not more than one of the three R groups is an alkyl.
25 9. The device of Claim 8 wherein said reaction proceeds by a free radical mechanism.
10. The device of Claim 9 wherein said free radical initiator is an organic peroxide.
30 11. The device of Claim 8 wherein said hydrolyzable silane is selected from vinyltrimethoxysilane, vinyltriethoxysilane, allytrimethoxysilane, γ-(meth)acryloxypropyltrimethoxysilane, and mixtures thereof.
12. A balloon catheter comprising a balloon wherein said balloon comprises a moisture cured polymeric material which is crosslinked through — Si— O— Si— linkages.
13. The balloon catheter of Claim 12 wherein said moisture cured polymeric material is the reaction product of: a) at least one polymer; and b) at least one hydrolyzable silane having the following general structure:
X — Si— Y, m
(3-m)
where X is a monovalent non-hydrolyzable organic moiety comprising at least one functional group W which is reactive with said polymer with the proviso that an Si-C bond is present between Si and W, Y is a hydrolyzable group, Z is a monovalent hydrocarbon group, and m is an integer from 1 to 3.
14. The balloon catheter of Claim 13 wherein said at least one hydrolyzable silane has an organofunctional group capable of readily reacting with a primary or secondary amine and said at least one polymer is amino functional.
15. The catheter balloon of Claim 13 wherein Y is an alkoxy of Cλ to C4.
16. The catheter balloon of Claim 13 wherein W is selected from (meth)acrylamido, (meth)acryloxy, carboxyl, epoxy, amino, ureido, isocyanato, thiocyanato, mercapto, styryl, vinyl, allyl, haloalkyl, acid anhydride, sulfonyl azide, carboxylic acid esters of aromatic alcohols, and mixtures thereof.
17. The catheter balloon of Claim 13 wherein X is selected from epoxycyclohexyl, glycidoxypropyl, isocyanatopropyl, vinyl, and allyl.
18. The catheter balloon of Claim 13 wherein said hydrolyzable silane is selected form isocyanatopropyltriethoxysilane, glycidoxypropyltrimethoxysilane and
2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane.
19. The catheter balloon of Claim 12 wherein said moisture cured polymeric material is the reaction product of: a) at least one polymer; and b) at least one hydrolyzable silane having the following general structure:
CH2 =C -(-C — 0 cπH2n) y)χSiR3
where R' is a hydrogen atom or lower Cj to C4 alkyl; x and y are 0 or 1 with the proviso that when x is 1, y is 1; n is an integer from 1 to 12 inclusive, preferably 1 to 4, and each R independently is a hydrolyzable organic group such as an alkoxy group having from 1 to 12 carbon atoms (e.g. methoxy, ethoxy, butoxy), aryloxy group (e.g. phenoxy), araloxy group (e.g. benzyloxy), aliphatic acyloxy group having from 1 to 12 carbon atoms (e.g. formyloxy, acetyloxy, propanoyloxy), amino or substituted amino groups (alkylamino, arylamino), or a lower alkyl group having 1 to 6 carbon atoms inclusive, with the proviso that not more than one of the three R groups is an alkyl.
20. A method of forming a catheter balloon comprising the steps of: a) providing at least one polymeric material at or above its melt temperature; b) providing at least one organofunctional hydrolyzable silane compound; c) extruding a) and b) into a tubular preform at a temperature wherein a) and b) react; d) forming said tubular preform into a balloon preform; e) blowing said balloon preform into a balloon; and
5 f) exposing said balloon or balloon preform to water; wherein said a) and b) react to form a polymeric material having hydrolyzable groups on said silane wherein said hydrolyzable groups crosslink upon exposure to water and form -Si-O-Si" linkages..
10 21. The method of Claim 20 wherein said at least one organofunctional hydrolyzable silane has the following general structure:
X — Si-Ym
z (3-m)
15 where X is a monovalent non-hydrolyzable organic moiety comprising at least one functional group W which is reactive with said polymeric material with the proviso that an Si-C bond is present between Si and W; Y is a hydrolyzable group, Z is a monovalent hydrocarbon group, and m is an integer from 1 to 3. 0
22. The method of Claim 20 wherein said at least one hydrolyzable silane has the following general structure:
R'
25
CH2 =C ~ -C — 0 CnH2n) y)χSiR3
where R' is a hydrogen atom or lower C, to C4 alkyl; x and y are 0 or 1 with the 30 proviso that when x is 1, y is 1; n is an integer from 1 to 12 inclusive, preferably
1 to 4, and each R independently is a hydrolyzable organic group such as an alkoxy group having from 1 to 12 carbon atoms, aryloxy group, araloxy group, aliphatic acyloxy group having from 1 to 12 carbon atoms, amino or substituted amino groups, or a lower alkyl group having 1 to 6 carbon atoms inclusive, with the proviso that not more than one of the three R groups is an alkyl. 5
23. The method of Claim 22 wherein said hydrolyzable silane is selected from vinyltrimethoxysilane, vinyltriethoxysilane, allytrimethoxysilane, and γ-(meth)acryloxypropyltrimethoxysilane.
10 24. The method of Claim 21 wherein W is selected from (meth)acrylamido, (meth)acryloxy, carboxyl, epoxy, amino, ureido, isocyanato, thiocyanato, mercapto, styryl, vinyl, allyl, haloalkyl, acid anhydride, sulfonyl azide, carboxylic acid esters of aromatic alcohols, and mixtures thereof.
15 25. The method of Claim 21 wherein X is selected from epoxycyclohexyl, glycidoxypropyl, isocyanatopropyl, vinyl, and allyl.
26. The method of Claim 21 wherein Y is alkoxy of Cλ to C4.
20 27. The method of Claim 21 wherein said hydrolyzable silane is selected form isocyanatopropyltriethoxysilane, glycidoxypropyltrimethoxysilane and 2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane.
28. The method of Claim 20 wherein said polymeric material is amino functional. 25
29. The method of Claim 20 wherein said exposure to water is accomplished in a water bath.
30. The method of Claim 20 wherein in during said blowing step, said balloon is 30 further axially stretched.
PCT/US2001/018515 2000-10-12 2001-06-08 Moisture curable balloon materials WO2002030483A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2002533922A JP2004518460A (en) 2000-10-12 2001-06-08 Moisture-curable balloon material
AT01944353T ATE301479T1 (en) 2000-10-12 2001-06-08 MOISTURE CURING BALLOON MATERIAL
AU2001266775A AU2001266775A1 (en) 2000-10-12 2001-06-08 Moisture curable balloon materials
DE60112598T DE60112598T2 (en) 2000-10-12 2001-06-08 MOISTURE HARDENING BALLOON MATERIAL
EP01944353A EP1324784B1 (en) 2000-10-12 2001-06-08 Moisture curable balloon materials
CA002425261A CA2425261A1 (en) 2000-10-12 2001-06-08 Moisture curable balloon materials

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/689,139 2000-10-12
US09/689,139 US6946174B1 (en) 2000-10-12 2000-10-12 Moisture curable balloon materials

Publications (1)

Publication Number Publication Date
WO2002030483A1 true WO2002030483A1 (en) 2002-04-18

Family

ID=24767203

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/018515 WO2002030483A1 (en) 2000-10-12 2001-06-08 Moisture curable balloon materials

Country Status (8)

Country Link
US (3) US6946174B1 (en)
EP (1) EP1324784B1 (en)
JP (1) JP2004518460A (en)
AT (1) ATE301479T1 (en)
AU (1) AU2001266775A1 (en)
CA (1) CA2425261A1 (en)
DE (1) DE60112598T2 (en)
WO (1) WO2002030483A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776351B2 (en) 2003-05-13 2010-08-17 Medtronic, Inc. Moisture curable materials for delivery of agents, methods, and medical devices

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7108826B2 (en) * 1994-03-02 2006-09-19 Boston Scientific Scimed, Inc. High compliance, high strength catheter balloons useful for treatment of gastrointestinal lesions
US7749585B2 (en) * 1996-10-08 2010-07-06 Alan Zamore Reduced profile medical balloon element
DE10320432A1 (en) * 2003-05-08 2004-12-02 Basf Coatings Ag Autocatalyzed, thermally curable compositions based on condensates of epoxy-functional silanes free from external catalysts and their use for the production of thermally hardened compositions
US9125968B2 (en) * 2005-03-30 2015-09-08 Boston Scientific Scimed, Inc. Polymeric/ceramic composite materials for use in medical devices
US7365126B2 (en) * 2005-09-16 2008-04-29 Boston Scientific Scimed, Inc. Medical device articles formed from polymer-inorganic hybrids prepared by ester-alkoxy transesterification reaction during melt processing
US8008395B2 (en) * 2005-09-27 2011-08-30 Boston Scientific Scimed, Inc. Organic-inorganic hybrid particle material and polymer compositions containing same
US8114515B2 (en) 2007-02-05 2012-02-14 Sabic Innovative Plastics Ip B.V. Crosslinked polyester compositions, method of manufacture, and uses thereof
US8141282B2 (en) * 2008-01-16 2012-03-27 Esselte Corporation Filing device with retractable tabs
JP5296875B2 (en) 2008-09-19 2013-09-25 カーディアック ペースメイカーズ, インコーポレイテッド Surface modification to improve lead lubricity, wear resistance and thermoelasticity
US11291483B2 (en) 2010-10-20 2022-04-05 206 Ortho, Inc. Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants
WO2015095745A1 (en) 2010-10-20 2015-06-25 206 Ortho, Inc. Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
US10525169B2 (en) 2010-10-20 2020-01-07 206 Ortho, Inc. Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
US11484627B2 (en) 2010-10-20 2022-11-01 206 Ortho, Inc. Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
WO2012054742A2 (en) 2010-10-20 2012-04-26 BIOS2 Medical, Inc. Implantable polymer for bone and vascular lesions
US11058796B2 (en) 2010-10-20 2021-07-13 206 Ortho, Inc. Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
US11207109B2 (en) 2010-10-20 2021-12-28 206 Ortho, Inc. Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
US9320601B2 (en) 2011-10-20 2016-04-26 206 Ortho, Inc. Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants
WO2014074147A1 (en) 2012-11-12 2014-05-15 Hollister Incorporated Intermittent catheter assembly and kit
LT2919825T (en) 2012-11-14 2018-12-10 Hollister Incorporated Disposable catheter with selectively degradable inner core
EP2999747B1 (en) 2013-05-23 2020-08-12 206 ORTHO, Inc. Apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone
CA2928646C (en) 2013-11-08 2020-05-05 Hollister Incorporated Oleophilic lubricated catheters
EP3079749B1 (en) 2013-12-12 2019-10-30 Hollister Incorporated Flushable catheters
HUE051611T2 (en) 2013-12-12 2021-03-01 Hollister Inc Flushable catheters
US10463833B2 (en) 2013-12-12 2019-11-05 Hollister Incorporated Flushable catheters
HUE051635T2 (en) 2013-12-12 2021-03-01 Hollister Inc Flushable disintegration catheter
WO2016205383A1 (en) 2015-06-17 2016-12-22 Hollister Incorporated Selectively water disintegrable materials and catheters made of such materials

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647630A (en) * 1982-11-05 1987-03-03 Ems-Inventa A.G. Process for the preparation of highly viscous or heat distortion-resistant polyamide which is at least partially crosslinked with functional silane
US5055249A (en) * 1988-06-07 1991-10-08 Ems-Inventa Ag Method for the manufacture of crosslinked polyamide articles
EP0651005A1 (en) * 1993-10-18 1995-05-03 Corvita Corporation Lubricious silicone surface modification
WO1996023531A1 (en) * 1995-02-03 1996-08-08 Smith & Nephew Plc Orthopaedic casting and splinting materials
EP0747070A2 (en) * 1995-06-06 1996-12-11 Advanced Cardiovascular Systems, Inc. Balloons for medical catheters

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146585A (en) 1977-03-02 1979-03-27 Union Carbide Corporation Process for preparing silane grafted polymers
US4198983A (en) 1978-04-28 1980-04-22 Baxter Travenol Laboratories, Inc. Catheter made of a thermoplastic material having improved softness and low friction
FR2513566A1 (en) * 1981-09-29 1983-04-01 Matburn Holdings Ltd METHOD FOR ATTACHING PLASTIC MATERIALS AND RUBBER TOGETHER
JPS58185647A (en) 1982-03-17 1983-10-29 Nippon Zeon Co Ltd Stable polymer emulsion composition giving antithrombotic surface and preparation thereof
US4567107A (en) 1982-05-05 1986-01-28 Essex Specialty Products, Inc. Acrylic resin having pendant silane groups thereon, and methods of making and using the same
US4430486A (en) 1982-11-29 1984-02-07 Ppg Industries, Inc. Film-forming urethane resins containing alkoxy silane groups and acrylyl groups
US4490421A (en) 1983-07-05 1984-12-25 E. I. Du Pont De Nemours And Company Balloon and manufacture thereof
US4675367A (en) 1984-08-30 1987-06-23 General Electric Company Silyl polyamides and method for their preparation
US4647690A (en) * 1984-10-22 1987-03-03 Phillips Petroleum Company Process for the production of allyl acetate
US4637640A (en) 1985-02-27 1987-01-20 Aeroquip Corporation Push-in connect fitting
US4673367A (en) * 1985-09-25 1987-06-16 Mattell, Inc. Animated figure toy
US4927413A (en) 1987-08-24 1990-05-22 Progressive Angioplasty Systems, Inc. Catheter for balloon angioplasty
US5017325A (en) 1988-10-04 1991-05-21 Cordis Corporation Stretch-blow molding method for manufacturing balloons for medical devices
US5356591A (en) 1988-10-04 1994-10-18 Cordis Corporation Tailoring expansion properties of balloons for medical devices
US6500146B1 (en) 1988-10-04 2002-12-31 Cordis Corporation Balloons for medical devices and fabrication thereof
US5055024A (en) 1988-10-04 1991-10-08 Cordis Corporation Apparatus for manufacturing balloons for medical devices
US5304197A (en) 1988-10-04 1994-04-19 Cordis Corporation Balloons for medical devices and fabrication thereof
US4938676A (en) 1988-10-04 1990-07-03 Cordis Corporation Apparatus for manufacturing balloons for medical devices
US5108415A (en) 1988-10-04 1992-04-28 Cordis Corporation Balloons for medical devices and fabrication thereof
US4906244A (en) 1988-10-04 1990-03-06 Cordis Corporation Balloons for medical devices and fabrication thereof
US5156612A (en) 1988-10-04 1992-10-20 Cordis Corporation Balloons for medical devices and fabrication thereof
US5223205A (en) 1988-10-04 1993-06-29 Cordis Corporation Method for manufacturing balloons for medical devices
US5236659A (en) 1988-10-04 1993-08-17 Cordis Corporation Tailoring expansion properties of balloons for medical devices
GB8826727D0 (en) * 1988-11-15 1988-12-21 Bp Chem Int Ltd Melamine/urea containing polymer polyols
JPH0372544A (en) * 1989-05-11 1991-03-27 Mitsui Toatsu Chem Inc Polypropylene resin composition
US4988778A (en) 1990-01-18 1991-01-29 Ppg Industries, Inc. Polyamine-functional silane resin
US5266627A (en) 1991-02-25 1993-11-30 Quantum Chemical Corporation Hydrolyzable silane copolymer compositions resistant to premature crosslinking and process
CA2061465A1 (en) * 1991-02-25 1992-08-26 Craig C. Meverden Filled hydrolyzable copolymer compositions resistant to premature crosslinking
US5439443A (en) 1991-09-30 1995-08-08 Nippon Zeon Co., Ltd. Balloon catheter
US5155233A (en) 1991-12-24 1992-10-13 Union Carbide Chemicals & Plastics Technology Corporation Inhibited epoxysilanes
US5250490A (en) 1991-12-24 1993-10-05 Union Carbide Chemicals & Plastics Technology Corporation Noble metal supported on a base metal catalyst
US5599352A (en) 1992-03-19 1997-02-04 Medtronic, Inc. Method of making a drug eluting stent
US5368566A (en) 1992-04-29 1994-11-29 Cardiovascular Dynamics, Inc. Delivery and temporary stent catheter having a reinforced perfusion lumen
US5569184A (en) 1992-04-29 1996-10-29 Cardiovascular Dynamics, Inc. Delivery and balloon dilatation catheter and method of using
US5227434A (en) 1992-08-26 1993-07-13 Olin Corporation Moisture curable polymers
US5348538A (en) 1992-09-29 1994-09-20 Scimed Life Systems, Inc. Shrinking balloon catheter having nonlinear or hybrid compliance curve
US5308641A (en) 1993-01-19 1994-05-03 Medtronic, Inc. Biocompatibility of solid surfaces
EP0696185B1 (en) 1993-04-28 1998-08-12 Focal, Inc. Apparatus, product and use related to intraluminal photothermoforming
US5465733A (en) 1993-10-14 1995-11-14 Hinohara; Tomoaki Guide wire for catheters and method for its use
DE4404041C1 (en) * 1994-02-09 1995-03-23 Ruesch Willy Ag Polymer material of medical instruments and process for preparing the polymer material
JP3523876B2 (en) 1994-02-17 2004-04-26 シメッド ライフ システムズ インコーポレイテッド Method for manufacturing catheter balloon
US5702734A (en) * 1994-12-19 1997-12-30 Electra Form, Inc. Take-out and cooling apparatus
US5702754A (en) 1995-02-22 1997-12-30 Meadox Medicals, Inc. Method of providing a substrate with a hydrophilic coating and substrates, particularly medical devices, provided with such coatings
US5824718A (en) 1995-04-20 1998-10-20 The Dow Chemical Company Silane-crosslinkable, substantially linear ethylene polymers and their uses
US5607475A (en) 1995-08-22 1997-03-04 Medtronic, Inc. Biocompatible medical article and method
EP0852594A1 (en) 1995-09-26 1998-07-15 Ameron International Corporation Polysiloxane polyurethane compositions
US5762996A (en) 1996-04-15 1998-06-09 Lucas; Daniel R. Silicone balloon catheter
JPH1033658A (en) * 1996-07-22 1998-02-10 Terumo Corp Extention catheter and its manufacture
US6656550B1 (en) 1996-10-08 2003-12-02 Alan M. Zamore Dilatation device of uniform outer diameter
US7749585B2 (en) 1996-10-08 2010-07-06 Alan Zamore Reduced profile medical balloon element
JPH10295801A (en) * 1997-04-25 1998-11-10 Nippon Zeon Co Ltd Balloon catheter
US5998551A (en) 1997-06-02 1999-12-07 Lawrence A. Acquarulo Crosslinked nylon block copolymers
US5948419A (en) 1997-12-30 1999-09-07 The Dumais Companies, L.L.C. Aqueous-based nail coating composition
DE69940561D1 (en) * 1998-08-20 2009-04-23 Kaneka Corp RESIN COMPOSITION, POLYMER AND METHOD FOR THE PRODUCTION THEREOF
US6218018B1 (en) * 1998-08-21 2001-04-17 Atofina Chemicals, Inc. Solar control coated glass
US6015920A (en) 1998-09-11 2000-01-18 Ck Witco Corporation Hydrosilation reaction process with recycle
US6299980B1 (en) * 1998-09-29 2001-10-09 Medtronic Ave, Inc. One step lubricious coating
US6077902A (en) 1998-10-14 2000-06-20 Bayer Corporation Moisture-curable compounds containing isocyanate and alkoxysilane groups
US6329488B1 (en) * 1998-11-10 2001-12-11 C. R. Bard, Inc. Silane copolymer coatings
JP2000279507A (en) * 1999-03-30 2000-10-10 Nippon Zeon Co Ltd Balloon catheter with low-temperature blow-molded balloon
FR2794295B1 (en) * 1999-05-31 2001-09-07 Joel Mercier ION GENERATING DEVICE

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647630A (en) * 1982-11-05 1987-03-03 Ems-Inventa A.G. Process for the preparation of highly viscous or heat distortion-resistant polyamide which is at least partially crosslinked with functional silane
US5055249A (en) * 1988-06-07 1991-10-08 Ems-Inventa Ag Method for the manufacture of crosslinked polyamide articles
EP0651005A1 (en) * 1993-10-18 1995-05-03 Corvita Corporation Lubricious silicone surface modification
US5736251A (en) * 1993-10-18 1998-04-07 Corvita Corporation Lubricious silicone surface modification
WO1996023531A1 (en) * 1995-02-03 1996-08-08 Smith & Nephew Plc Orthopaedic casting and splinting materials
EP0747070A2 (en) * 1995-06-06 1996-12-11 Advanced Cardiovascular Systems, Inc. Balloons for medical catheters

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776351B2 (en) 2003-05-13 2010-08-17 Medtronic, Inc. Moisture curable materials for delivery of agents, methods, and medical devices

Also Published As

Publication number Publication date
US7182906B2 (en) 2007-02-27
DE60112598D1 (en) 2005-09-15
EP1324784A1 (en) 2003-07-09
JP2004518460A (en) 2004-06-24
US20070073378A1 (en) 2007-03-29
US6946174B1 (en) 2005-09-20
ATE301479T1 (en) 2005-08-15
US20050238831A1 (en) 2005-10-27
EP1324784B1 (en) 2005-08-10
DE60112598T2 (en) 2006-04-06
CA2425261A1 (en) 2002-04-18
AU2001266775A1 (en) 2002-04-22
US8137777B2 (en) 2012-03-20

Similar Documents

Publication Publication Date Title
US8137777B2 (en) Moisture curable balloon materials
US6086556A (en) Medical device balloons containing thermoplastic elastomers
US7618696B2 (en) Block copolymer elastomer catheter balloons
US6328925B1 (en) Laminate catheter balloons with additive burst strength and methods for preparation of same
US6896842B1 (en) Medical device balloons containing thermoplastic elastomers
US5951941A (en) Block copolymer elastomer catheter balloons
US5441488A (en) Medical tool having lubricious surface in a wetted state and method for production thereof
JPH09509860A (en) Block copolymer elastomer, catheter, balloon
US20030195490A1 (en) Medical device including unitary, continuous portion of varying durometer
JP2002503989A (en) Lubricity gradients for medical devices
JP2007518449A (en) Protective coating for medical equipment
US20070197961A1 (en) Block copolymer elastomer catheter balloons
WO2001019425A9 (en) Medical device including expandable balloon
JPH10277157A (en) Balloon expansion catheter and manufacture thereof
WO1996003164A1 (en) Hydrophilic coating material for intracorporeal use
US20040197501A1 (en) Catheter balloon formed of a polyurethane of p-phenylene diisocyanate and polycaprolactone
JPH027668B2 (en)
CA2173139C (en) Medical device balloons containing thermoplastic elastomers
CA2184383C (en) Block copolymer elastomer catheter balloons
JP2001029453A (en) Antithrombotic balloon catheter
JPS6219871B2 (en)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2425261

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002533922

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2001944353

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001944353

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2001944353

Country of ref document: EP